Saturn V Capital Management LLC Ironwood Pharmaceuticals Inc Transaction History
Saturn V Capital Management LLC
- $265 Billion
- Q2 2024
A detailed history of Saturn V Capital Management LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Saturn V Capital Management LLC holds 1,113,824 shares of IRWD stock, worth $4.62 Million. This represents 2.74% of its overall portfolio holdings.
Number of Shares
1,113,824
Previous 944,912
17.88%
Holding current value
$4.62 Million
Previous $8.23 Billion
11.76%
% of portfolio
2.74%
Previous 3.3%
Shares
2 transactions
Others Institutions Holding IRWD
# of Institutions
247Shares Held
170MCall Options Held
11.2MPut Options Held
28.5K-
Black Rock Inc. New York, NY22.9MShares$94.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$89.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$68 Million18.04% of portfolio
-
State Street Corp Boston, MA9.24MShares$38.4 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA8.91MShares$37 Million0.15% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $636M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...